Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.

Siegfried Holding AG

Pharma Manufacturing provides information and resources related to the pharmaceutical manufacturing sector, including industry news, articles, and events.

Pharma Manufacturing

Siegfried AG is a contract development and manufacturing organization that produces pharmaceutical ingredients and finished products as an integrated supplier. It leverages its pharmaceutical and chemical experience to take innovations to industrial scale.

Metric
Company Name	Siegfried Holding AG	Pharma Manufacturing
Symbol	SFZN
MSH ID	CH:SIEGFRIED	COM:PHARMAMANUFACTURING
Market	STOCKS	PRIVATE
Sector		Commercial & Professional Services
Industry		Pharmaceuticals
Country	CH	US
Stage
Employee Count	3.63K
Website	siegfried.ch	pharmamanufacturing.com
LinkedIn
Founders

Metric
Market Cap	4.14B
Enterprise Value
Monthly Web Traffic		6.54K
Web Traffic Growth		-0.82
Valuation
Raised Capital

Metric
Revenue	1.45B
Revenue (LTM)
Revenue (NTM)
Gross Profit	365.24M
EBITDA	270.88M
Operating Income	196.14M
Net Income	128.55M
EPS	30.33
Diluted EPS	29.89
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.26
Operating Profit Margin	0.14
EBITDA Margin	0.19
Net Profit Margin	0.10
Return on Equity	0.15
Return on Assets	0.07
Return on Capital Employed	0.12

CH:SIEGFRIED

Siegfried AG

Last Close

1,114.00

25/11 09:20

Market Cap

3.63B

Beta: -

Volume Today

250

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	22.59
P/B Ratio	4.47
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.95
EV Multiple	17.63

Metric
Days Sales Outstanding	127.47
Days Payables Outstanding	45.72
Days Inventory Outstanding	178.19
Operating Cycle	304.80
Cash Conversion Cycle	266.86
Asset Turnover	0.68

Metric
Operating Cash Flow	237.80M
Free Cash Flow	81.52M
Cash Flow to Debt	0.57
Operating Cash Flow/Sales	0.19
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	64.25M
Accounts Receivable	-20.29M
Inventory	492.38M
Goodwill
Debt to Capitalization	0.36
Debt to Assets
Current Ratio	2.98
Quick Ratio	1.40

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.04
SG&A to Revenue	0.03